Arrowhead Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US04280A1007

SecurityARWR / Arrowhead Pharmaceuticals, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Barclays Plc ownership in ARWR / Arrowhead Pharmaceuticals, Inc.

On May 15, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 0 shares of Arrowhead Pharmaceuticals, Inc. (US:ARWR) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 321,833 shares of Arrowhead Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (ARWR) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ARWR / Arrowhead Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -321,833 -100.00 0 -100.00
2026-05-15 2026-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 0 -321,833 -100.00 0 -100.00
2026-02-13 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 321,833 -28,406 -8.11 21,366 76.89 0.0051
2026-03-31 2025-09-30 13F/A-3 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 350,239 -59,364 -14.49 12,080 86.66 0.0026
2026-03-19 2025-09-30 13F/A-2 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 276,610 -132,993 5,358 0.0014
2025-11-12 2025-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 350,239 -59,364 12,080 0.0026
2026-02-27 2025-06-30 13F/A-2 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 409,603 179,465 77.98 6,472 120.78 0.0015
2025-08-14 2025-06-30 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 409,603 179,465 6 0.0015
2025-08-13 2025-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 409,603 179,465 6 0.0005
2026-03-17 2025-03-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 230,138 -82,422 -26.37 2,932 -50.12 0.0008
2025-05-15 2025-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 230,138 -82,422 3 0.0008
2026-03-19 2024-12-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 312,560 35,950 13.00 5,876 9.69 0.0016
2025-02-13 2024-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 312,560 35,950 6 0.0016
2026-03-31 2024-09-30 13F/A-2 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 276,610 167,556 153.64 5,358 89.03 0.0014
2024-11-19 2024-09-30 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 276,610 167,556 5 0.0014
2024-11-15 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 276,610 167,556 5 0.0004
2026-03-23 2024-06-30 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 109,054 -114,094 -51.13 2,834 -55.59 0.0009
2024-08-14 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 109,054 -114,094 3 0.0009
2026-03-24 2024-03-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 223,148 -138,809 -38.35 6,382 -42.37 0.0022
2024-05-15 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 223,148 -138,809 6 0.0022
2026-03-25 2023-12-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 361,957 164,234 83.06 11,076 108.49 0.0041
2024-02-15 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 361,957 164,234 11 0.0041
2026-03-26 2023-09-30 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 197,723 -159,158 -44.60 5,313 -58.26 0.0033
2023-11-07 2023-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 197,723 -159,158 5 0.0033
2026-03-30 2023-06-30 13F/A-2 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 356,881 40,899 12.94 12,726 58.58 0.0081
2023-09-20 2023-06-30 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 356,881 40,899 13 0.0081
2023-08-03 2023-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 356,881 40,899 13 0.0080
2026-03-30 2023-03-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 315,982 -23,199 -6.84 8,026 -41.67 0.0037
2023-05-04 2023-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 315,982 -23,199 8 0.0037
2026-03-30 2022-12-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 339,181 40,884 13.71 13,757 39.54 0.0062
2023-02-13 2022-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 339,181 40,884 14 0.0062
2022-11-03 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 298,297 106,537 55.56 9,859 46.02 0.0108
2022-08-12 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 191,760 45,851 31.42 6,752 0.63 0.0041
2022-05-16 2022-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 145,909 -121,413 -45.42 6,710 -62.14 0.0053
2022-02-23 2021-12-31 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 267,322 49,938 22.97 17,724 30.60 0.0066
2022-02-14 2021-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 267,322 49,938 17,724 0.0020
2021-11-09 2021-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 217,384 10,315 4.98 13,571 -20.86 0.0061
2021-08-13 2021-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 207,069 -17,366 -7.74 17,148 15.22 0.0081
2021-05-13 2021-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 224,435 60,039 36.52 14,883 17.98 0.0080
2021-02-11 2020-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 164,396 -34,567 -17.37 12,615 47.23 0.0067
2020-11-12 2020-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 198,963 3,441 1.76 8,568 1.46 0.0051
2020-08-12 2020-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 195,522 9,574 5.15 8,445 57.82 0.0065
2020-05-13 2020-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 185,948 43,135 30.20 5,351 -40.93 0.0042
2020-02-10 2019-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 142,813 32,266 29.19 9,058 190.69 0.0050
2019-11-15 2019-09-30 13F/A-1 ARROWHEAD PHARMACEUTICALS IN COM 04280A100 110,547 -7,583 -6.42 3,116 -0.48 0.0019
2019-11-14 2019-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 110,547 -7,583 3,116 720.4227
2019-08-14 2019-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 118,130 48,596 69.89 3,131 145.18 0.0019
2019-05-15 2019-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 69,534 57,169 462.35 1,277 734.64 0.0009
2019-02-14 2018-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 12,365 -42,985 -77.66 153 -85.59 0.0001
2018-11-14 2018-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 55,350 -8,802 -13.72 1,062 21.65 0.0007
2018-08-14 2018-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 64,152 -66,020 -50.72 873 -6.93 0.0008
2018-05-15 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 130,172 -20,101 -13.38 938 69.62 0.0007
2018-02-14 2017-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 150,273 92,308 159.25 553 120.32 0.0005
2017-11-14 2017-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 57,965 -94,833 -62.06 251 1.62 0.0003
2017-08-14 2017-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 152,798 104,406 215.75 247 174.44 0.0003
2017-05-15 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 48,392 22,387 86.09 90 130.77 0.0001
2017-02-14 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 26,005 833 3.31 39 -78.92 0.0000
2016-11-14 2016-09-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 25,172 17,612 232.96 185 374.36 0.0002
2016-08-12 2016-06-30 13F ARROWHEAD PHARMACEUTICALS IN COM 04280A100 7,560 7,560 39 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-03-19 2025-09-30 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Call 25,000 484 n/a n/a n/a
2026-03-19 2024-12-31 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 0 0 n/a n/a n/a
2024-11-19 2024-09-30 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Call 25,000 0 n/a n/a n/a
2026-03-31 2024-09-30 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Call 25,000 484 n/a n/a n/a
2024-11-15 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 25,000 0 n/a n/a n/a
2026-03-23 2024-06-30 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 0 0 n/a n/a n/a
2026-03-24 2024-03-31 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Call 53,000 76.67 1,516 65.03 n/a n/a n/a
2024-05-15 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 53,000 2 n/a n/a n/a
2026-03-25 2023-12-31 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Call 30,000 918 n/a n/a n/a
2024-02-15 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 30,000 1 n/a n/a n/a
2022-11-03 2022-09-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-12 2022-06-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 46,000 1,620 n/a n/a n/a
2017-08-14 2017-06-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 16,300 63.00 30 87.50 n/a n/a n/a
2017-02-14 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 10,000 -2.91 16 -78.95 n/a n/a n/a
2016-11-14 2016-09-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 10,300 47.14 76 105.41 n/a n/a n/a
2016-08-12 2016-06-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Call 7,000 37 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-03-19 2025-09-30 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Put 25,000 484 n/a n/a n/a
2026-03-19 2024-12-31 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 0 0 n/a n/a n/a
2024-11-19 2024-09-30 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Put 25,000 0 n/a n/a n/a
2026-03-31 2024-09-30 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Put 25,000 484 n/a n/a n/a
2024-11-15 2024-09-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 25,000 0 n/a n/a n/a
2026-03-23 2024-06-30 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 0 0 n/a n/a n/a
2026-03-24 2024-03-31 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Put 53,000 76.67 1,516 65.03 n/a n/a n/a
2024-05-15 2024-03-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 53,000 2 n/a n/a n/a
2026-03-25 2023-12-31 13F/A ARROWHEAD PHARMACEUTICALS IN OPT Put 30,000 918 n/a n/a n/a
2024-02-15 2023-12-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 30,000 1 n/a n/a n/a
2018-05-15 2018-03-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 1,500 0.00 6 0.00 n/a n/a n/a
2017-11-14 2017-09-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 1,500 0.00 6 200.00 n/a n/a n/a
2017-08-14 2017-06-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 1,500 -85.00 2 -89.47 n/a n/a n/a
2017-05-15 2017-03-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 10,000 108.33 19 171.43 n/a n/a n/a
2017-02-14 2016-12-31 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 4,800 11.63 7 -78.12 n/a n/a n/a
2016-11-14 2016-09-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 4,300 7.50 32 52.38 n/a n/a n/a
2016-08-12 2016-06-30 13F ARROWHEAD PHARMACEUTICALS IN OPT Put 4,000 21 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.